RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in RVL Pharmaceuticals plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q1 2022
- Shares held
- 16.4M
- −60.9K (−0.4%) vs. Q1 2022
- Total value
- $22.2M
- −$5.56M (−20.0%) vs. Q1 2022
- New holders
- 6
- 5 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 8,148,832 | $11.1M | 4.66% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 3,000,000 | $4.02M | 1.03% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $2.21M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 1,220,753 | $1.66M | 0.00% | −53,164−4.2% | Reduced |
| Renaissance Technologies LLC | 840,507 | $1.14M | 0.00% | −146,216−14.8% | Reduced |
| Geode Capital Management, LLC | 262,777 | $357.0K | 0.00% | +9,692+3.8% | Added |
| Vanguard Group Inc | 222,435 | $302.0K | 0.00% | +14,493+7.0% | Added |
| BlackRock Inc. | 207,178 | $282.0K | 0.00% | −5,009−2.4% | Reduced |
| Marietta Wealth Management, LLC | 120,000 | $163.0K | 0.04% | 00.0% | Unchanged |
| Titleist Asset Management, Ltd. | 118,303 | $161.0K | 0.04% | +15,033+14.6% | Added |
| AIGH Capital Management LLC | 84,993 | $116.0K | 0.05% | +84,993 | New |
| Dimensional Fund Advisors LP | 72,623 | $99.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 72,187 | $98.0K | 0.00% | +33,403+86.1% | Added |
| Northern Trust Corp | 71,091 | $97.0K | 0.00% | −3,860−5.2% | Reduced |
| Millennium Management LLC | 48,125 | $65.0K | 0.00% | +48,125 | New |
| Insight Advisors, LLC | 37,823 | $59.0K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 32,713 | $45.0K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 27,000 | $37.0K | 0.00% | −8,400−23.7% | Reduced |
| Prudential Financial Inc | 25,000 | $34.0K | 0.00% | +25,000 | New |
| Wells Fargo & Company | 23,874 | $32.0K | 0.00% | +23+0.1% | Added |
| Two Sigma Investments, LP | 22,413 | $30.0K | 0.00% | −64,524−74.2% | Reduced |
| Engineers Gate Manager LP | 21,870 | $30.0K | 0.00% | −5,318−19.6% | Reduced |
| Two Sigma Advisers, LP | 17,400 | $24.0K | 0.00% | −400−2.2% | Reduced |
| Bank of New York Mellon Corp | 12,078 | $16.0K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| SFMG, LLC | 10,000 | $14.0K | 0.00% | +10,000 | New |
| Tower View Investment Management & Research LLC | 4,100 | $6.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 1,650 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,187 | $2.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,598 | $2.00K | 0.00% | +1,598 | New |
| The PNC Financial Services Group, Inc. | 700 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 7 | $10 | 0.00% | −100−93.5% | Reduced |
| Royal Bank of Canada | 84 | $0 | 0.00% | −2,043−96.1% | Reduced |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 225 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 75 | $0 | 0.00% | +75 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,954−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,022−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |